Increased expression of MYB was detected in cisplatin-resistant colorectal carcinoma (CRC) cells, and treatment with a c-myb antisense oligonucleotide sensitized these resistant cells to cisplatin, indicating a significant role of MYB in cisplatin resistance of CRCs[37]. The gene discussed is MYB; the disease is colorectal carcinoma.